Singapore markets closed

Aadi Bioscience, Inc. (AADI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
14.79+0.44 (+3.07%)
At close: 04:00PM EDT
14.79 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 300.52M
Enterprise value 171.26M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)90.87
Price/book (mrq)2.41
Enterprise value/revenue 51.79
Enterprise value/EBITDA -1.45

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-43.33%
S&P500 52-week change 3-7.05%
52-week high 349.80
52-week low 311.00
50-day moving average 316.23
200-day moving average 322.54

Share statistics

Avg vol (3-month) 3103.03k
Avg vol (10-day) 3127.28k
Shares outstanding 520.94M
Implied shares outstanding 6N/A
Float 815M
% held by insiders 113.59%
% held by institutions 163.26%
Shares short (28 Apr 2022) 4513.43k
Short ratio (28 Apr 2022) 46.1
Short % of float (28 Apr 2022) 43.58%
Short % of shares outstanding (28 Apr 2022) 42.45%
Shares short (prior month 30 Mar 2022) 4574.79k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 326 Aug 2021

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,414.82%

Management effectiveness

Return on assets (ttm)-37.07%
Return on equity (ttm)-221.95%

Income statement

Revenue (ttm)3.31M
Revenue per share (ttm)0.25
Quarterly revenue growth (yoy)1,822.50%
Gross profit (ttm)-18.55M
EBITDA -46.61M
Net income avi to common (ttm)-119.12M
Diluted EPS (ttm)-8.81
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)129.85M
Total cash per share (mrq)6.2
Total debt (mrq)587k
Total debt/equity (mrq)0.47
Current ratio (mrq)11.78
Book value per share (mrq)5.95

Cash flow statement

Operating cash flow (ttm)-52.4M
Levered free cash flow (ttm)-41.37M